Simplex Trading
FSTX

Simplex Trading’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Simplex Trading’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-17,400
Closed -$109K – 10638
2022
Q4 		$109K Buy
17,400
+9,300
+115% +$51.5K ﹤0.01% 4967
2022
Q3 		$41K Buy
8,100
+2,900
+56% +$18.2K ﹤0.01% 6722
2022
Q2 		$32K Buy
5,200
+3,500
+206% +$11.8K ﹤0.01% 7084
2022
Q1 		$6K Sell
1,700
-1,200
-41% -$4.43K ﹤0.01% 9370
2021
Q4 		$14K Buy
2,900
+100
+4% +$603 ﹤0.01% 8782
2021
Q3 		$23K Hold
2,800
– – ﹤0.01% 8334
2021
Q2 		$24K Buy
+2,800
New +$23.9K ﹤0.01% 8452

Simplex Trading's FSTX Position: Q4 2022 in Review

Simplex Trading sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q4 2022, closing a stake of 340 shares — an estimated $1.88K sold.

Simplex Trading first reported a position in FSTX in Q4 2021 and held it in 3 quarters. The position peaked at $54K in Q2 2022. 59 funds tracked by Wall St. Rank hold FSTX as of Q4 2022.

  • Simplex Trading reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Simplex Trading sold 340 F-star Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $1.88K.
  • Simplex Trading first reported a position in F-star Therapeutics, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • Simplex Trading's F-star Therapeutics, Inc. Common Stock position peaked at $54K in Q2 2022.
  • 59 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.